Bristol-Myers Squibb Company

NYSE: BMY
$48.18
+$1.73 (+3.7%)
Closing Price on May 12, 2025

BMY Stock Chart and Intraday Price

BMY Stock Data

Asset Type Stock
Exchange NYSE
Currency USD
Country USA
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address 430 E. 29TH STREET, 14 FLOOR, NEW YORK, NY, US
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 102,909.25M USD
Shares Outstanding 2,022,190,000
Bristol-Myers Squibb Company is a global biopharmaceutical firm focused on discovering, developing, and delivering innovative medicines for a range of serious diseases. With a rich history dating back to 1887, it specializes in treatments across hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience fields. Its portfolio includes notable drugs like Eliquis, Opdivo, and Sprycel, targeting conditions from cancer to multiple sclerosis. The company markets its products to a variety of clients, including hospitals, pharmacies, and government agencies, aiming to improve patient health outcomes worldwide.

BMY Articles

Live Updates Live Coverage Has Ended Pharmaceutical Stocks are Still Erasing Earlier Losses 11:44 am Following the initial shock from President Trump’s drug cost announcement, many of the top...
These five top recession-resistant stocks will weather the potential economic storm while paying reliable, high-yield dividends.
These five safety net portfolio stocks pay a 5% or higher dividend and have consistently raised their payouts over many decades.
Four healthcare dividend stocks with significant upside potential and safe dividends look like outstanding ideas for investors worn out from tariff-related volatility.
Good news: these four high-quality dividend giants are currently available at attractive prices and offering excellent entry points.
Large-cap pharmaceutical stocks like these may now be positioned to outperform as the impact of tariffs begins to take hold.
As hedge funds dump tech stocks, these four high-yield dividend stocks make sense for investors regardless of age or investment strategy.
Investors looking for hefty dividend payouts and a relative sense of safety have a wide menu of choices nowadays. Among the standouts in the world of exchange traded funds (ETFs) are the JPMorgan...
The stock market has been a wild roller coaster ride for the past five years, shifting from bull market to bear and back numerous times. It was a good lesson that stocks don’t just rise in a...
These four high-yield blue chip stocks have dependable and growing dividends that provide reliable streams of passive income.
Growth and income investors who stayed with some of Wall Street's favorite high-yield dividend stocks have had reason to cheer lately.
These high-yield dividend stocks are outstanding ideas for growth and income investors now, as they hold up better during recessions.
Johnson & Johnson has rewarded shareholders again with a quarterly dividend. As a Dividend King, it is the epitome of a steady and reliable stock.
Four top companies all pay at least a 4% dividend are on sale and make sense for investors who may be worried about increased volatility in the stock market.
AbbVie just rewarded its shareholders again with a dividend. This stock has boosted its payout annually for more than 50 years.